Paper Details

  1. Home
  2. Paper Details

Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma.

Author: Ben SalahRaja, ChauhanBhupendrasinh F, DucharmeFrancine M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

For children with persistent asthma, low-dose inhaled corticosteroids (ICS) are the recommended first-line treatment. When asthma isn't well-controlled with low-dose ICS, adding an anti-leukotriene medication is one option for increasing treatment intensity.
Paper Details　
Original Abstract of the Article :
In the treatment of children with mild persistent asthma, low-dose inhaled corticosteroids (ICS) are recommended as the preferred monotherapy (referred to as step 2 of therapy). In children with inadequate asthma control on low doses of ICS (step 2), asthma management guidelines recommend adding an ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD009585.pub2

データ提供：米国国立医学図書館（NLM）

Anti-Leukotriene Agents for Persistent Asthma: A Desert Oasis of Options

Asthma, a chronic respiratory condition, is like a persistent desert wind that can make breathing difficult. This study focused on persistent asthma in children, a condition that can be as challenging as navigating a desert without a compass. They explored the use of anti-leukotriene agents, medications that block the action of leukotrienes, a group of chemicals that trigger inflammation in the airways. The researchers reviewed current guidelines for asthma management in children, finding that anti-leukotriene agents can be added to inhaled corticosteroids, a standard treatment for asthma, when the asthma is not adequately controlled. This study, as clear as a desert sky after a dust storm, provides valuable insights into the management of persistent asthma in children.

Anti-Leukotriene Agents: A Desert Oasis of Asthma Control

This study, as vast as the desert itself, confirms that anti-leukotriene agents can be a valuable addition to inhaled corticosteroids for children with persistent asthma. The results, as clear as a desert well after a long trek, highlight the importance of tailoring treatment to individual needs, ensuring the most effective and safe asthma management.

Asthma Management in Children: Navigating the Desert Landscape

Asthma can be a challenging condition for children, affecting their quality of life and ability to participate in daily activities. This study, like a well-marked trail in the desert, provides valuable information for clinicians and families seeking to manage persistent asthma in children. The addition of anti-leukotriene agents to inhaled corticosteroids can be a helpful tool for improving asthma control and ensuring a better quality of life for children living with this condition.

Dr. Camel's Conclusion

This study underscores the importance of anti-leukotriene agents in the management of persistent asthma in children. These agents, when combined with inhaled corticosteroids, can be a valuable oasis of options for those seeking better asthma control and improved quality of life.
Date :
  1. Date Completed 2014-04-28
  2. Date Revised 2022-01-29
Further Info :

Pubmed ID

24089325

DOI: Digital Object Identifier

10.1002/14651858.CD009585.pub2

Related Literature

Article Analysis
・Effective treatment of asthma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.